Back
3D Systems Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
27
DDD
3D Systems
Last Price:
3.07
Seasonality Move:
-5.95%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
27
3D Systems (DDD)
is a Sell
Is 3D Systems a Buy, Sell or Hold?
- The current 3D Systems [DDD] share price is $3.07. The Score for DDD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- DDD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DDD Stock Price Chart
What is 3D Systems's stock price today?
-
The 3D Systems share price today is $3.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DDD is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
DDD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 33.88 | Sell |
Chaikin Money Flow: | 1084214 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.26 - 3.94) | Sell |
Bollinger Bands (100): | (3.44 - 4.68) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.91 | Buy |
Relative Strength Index (14 RSI): | 86.77 | Buy |
Chaikin Money Flow: | -1210062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.8 - 205.74) | Buy |
Bollinger Bands (100): | (136.44 - 176.64) | Buy |
DDD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.29 | Sell |
20-day SMA: | 3.61 | Sell |
50-day SMA: | 3.6 | Sell |
200-day SMA: | 4.52 | Sell |
8-day EMA: | 3.26 | Sell |
20-day EMA: | 3.48 | Sell |
50-day EMA: | 3.69 | Sell |
200-day EMA: | 4.89 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 209.44 | Buy |
20-day SMA: | 176.25 | Buy |
50-day SMA: | 159.62 | Buy |
200-day SMA: | 165.96 | Buy |
8-day EMA: | 218.01 | Buy |
20-day EMA: | 188.75 | Buy |
50-day EMA: | 168.9 | Buy |
200-day EMA: | 168.09 | Buy |
3D Systems Earnings Growth & DDD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.03 per share, and an increase next year of $0.13 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
3D Systems Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |